Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Blood Loss and Visibility With Esmolol vs. Labetalol in Endoscopic Sinus Surgery: A Randomized Trial

NCT03661346 is registered in ClinicalTrials.gov with The University of Texas Medical Branch, Galveston as lead sponsor.

NCT NCT03661346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03661346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Blood Loss and Visibility With Esmolol vs. Labetalol in Endoscopic Sinus Surgery: A Randomized Trial
Lead sponsor
The University of Texas Medical Branch, Galveston
Phase
Phase 2
Overall status
Completed
Start date
March 1, 2017
Completion date
March 30, 2018
Enrollment
28 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic sinusitis